Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsia
- Conditions
- Toxemia of Pregnancy10010273
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 44
Women (>=18 years) with a singleton pregnancy diagnosed with PE with a
gestational age between >= 20 weeks and <35 weeks admitted to the obstetric
department who give written informed consent, will be included.
- Multiple pregnancies , - Not willing to give written informed consent., -
Other reasons than (suspected) PE requiring hospitalization, - The use of PPI
at time of randomization, - Contraindications or hypersensitivity to PPI use, -
The use of medication affected by PPI , - Fetal death at time of inclusion, -
Signs of fetal distress at time of inclusion, - Expected delivery of <= 2 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method